Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of α-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins

Chemical Research in Toxicology

Volumn 18, Issue 8, 2005, Pages 1232-1241

  Zeng, Jingmin ^a   Davies, Michael J ^a  

^a HEART RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DICARBONYL DERIVATIVE; ADVANCED GLYCATION END PRODUCT; ALDEHYDE DERIVATIVE; AMINO ACID; ARGININE; CARBOCISTEINE; GLUCOSE; GLYOXAL; LYSINE; METHYLGLYOXAL; PEPTIDE DERIVATIVE; PROTEIN; SERUM ALBUMIN; THIOL GROUP;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CONCENTRATION RESPONSE; DIABETES MELLITUS; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERGLYCEMIA; HYPOTHESIS; OXIDATION; QUANTITATIVE ANALYSIS; REACTION ANALYSIS; VASCULAR DISEASE;

AMINO ACIDS; CARBOCYSTEINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; GLYOXAL; PEPTIDES; PROTEINS; SERUM ALBUMIN, BOVINE; SPECTROMETRY, FLUORESCENCE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SULFHYDRYL COMPOUNDS;

EID: 23844502010     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx050074u     Document Type: Article

References (66)

1. Di Mario, U., and Pugliese, G. (2001) 15th Golgi lecture: from hyperglycaemia to the dysregulation of vascular remodelling in diabetes. Diabetologia 44, 674-692.
2. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329, 977-986.
3. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352, 837-853.
4. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352, 854-865.
5. Kuusisto, J., Mykkanen, L., Pyorala, K., and Laakso, M. (1994) NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 43, 960-967.
6. Nishikawa, T., Sasahara, T., Kiritoshi, S., Sonoda, K., Senokuchi, T., Matsuo, T., Kukidome, D., Wake, N., Matsumura, T., Miyamura, N., Sakakida, M., Kishikawa, H., and Araki, E. (2003) Evaluation of urinary 8-hydroxydeoxy- guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 26, 1507-1512.
7. Cooper, M. E., Gilbert, R. E., and Jerums, G. (1997) Diabetic vascular complications. Clin. Exp. Pharmacol. Physiol. 24, 770-775.
8. Jenkins, A. J., Best, J. D., Klein, R. L., and Lyons, T. J. (2004) Lipoproteins, glycoxidation and diabetic angiopathy. Diabetes/ Metab. Res. Rev. 20, 349-368.
9. Brownlee, M. (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414, 813-820.
10. Fu, M. X., Requena, J. R., Jenkins, A. J., Lyons, T. J., Baynes, J. W., and Thorpe, S. R. (1996) The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 271, 9982-9986.
11. Hazen, S. L., Hsu, F. F., d'Avignon, A., and Heinecke, J. W. (1998) Human neutrophils employ myeloperoxidase to convert alpha-amino acids to a battery of reactive aldehydes: a pathway for aldehyde generation at sites of inflammation. Biochemistry 37, 6864-6873.
12. Anderson, M. M., Hazen, S. L., Hsu, F. F., and Heinecke, J. W. (1997) Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,- beta-unsaturated aldehydes by phagocytes at sites of inflammation. J. Clin. Invest. 99, 424-432.
13. Baynes, J. W. (2003) Chemical modification of proteins by lipids in diabetes. Clin. Chem. Lab. Med. 41, 1159-1165.
14. Baynes, J. W., and Thorpe, S. R. (2000) Glycoxidation and lipoxidation in atherogenesis. Free Radical Biol. Med. 28, 1708-1716.
15. Davies, M. J. (2004) The oxidative environment and protein damage. Biochim. Biophys. Acta 1703, 93-109.
16. Lo, T. W., Westwood, M. E., McLellan, A. C., Selwood, T., and Thornalley, P. J. (1994) Binding and modification of proteins by methylglyoxal under physiological conditions. A kinetic and mechanistic study with N alpha-acetylarginine, N alpha-acetyl-cysteine, and N alpha-acetyllysine, and bovine serum albumin. J. Biol. Chem. 269, 32299-32305.
17. Hunt, J. V., and Wolff, S. P. (1991) The role of histidine residues in the nonenzymic covalent attachment of glucose and ascorbic acid to protein. Free Radical Res. Commun. 14, 279-287.
18. Munch, G., Schicktanz, D., Behme, A., Gerlach, M., Riederer, P., Palm, D., and Schinzel, R. (1999) Amino acid specificity of glycation and protein-AGE crosslinking reactivities determined with a dipeptide SPOT library. Nat. Biotechnol. 17, 1006-1010.
19. Knott, H. M., Brown, B. E., Davies, M. J., and Dean, R. T. (2003) Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles. Eur. J. Biochem. 270, 3572-3582.
20. Vlassara, H., and Palace, M. R. (2002) Diabetes and advanced glycation endproducts. J. Intern. Med. 251, 87-101.
21. Zimmermann, R., Panzenbock, U., Wintersperger, A., Levak-Frank, S., Graier, W., Glatter, O., Fritz, G., Kostner, G. M., and Zechner, R. (2001) Lipoprotein lipase mediates the uptake of glycated LDL in fibroblasts, endothelial cells, and macrophages. Diabetes 50, 1643-1653.
22. Bierhaus, A., Hofmann, M. A., Ziegler, R., and Nawroth, P. P. (1998) AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc. Res. 37, 586-600.
23. Schmidt, A. M., and Stern, D. (2000) Atherosclerosis and diabetes: the RAGE connection. Curr. Atheroscler. Rep. 2, 430-436.
24. Singh, R., Barden, A., Mori, T., and Beilin, L. (2001) Advanced glycation end-products: a review. Diabetologia 44, 129-46.
25. Forbes, J. M., Thallas-Bonke, V., Cooper, M. E., and Thomas, M. C. (2004) Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy. Curr. Pharm. Des. 10, 3361-3372.
26. Morgan, P. E., Dean, R. T., and Davies, M. J. (2002) Inactivation of cellular enzymes by carbonyls and protein-bound glycation/ glycoxidation products. Arch. Biochem. Biophys. 403, 259-269.
27. Ahmed, M. U., Thorpe, S. R., and Baynes, J. W. (1986) Identification of N epsilon-carboxymethyllysine as a degradation product of fructoselysine in glycated protein. J. Biol. Chem. 261, 4889-4894.
28. Iijima, K., Murata, M., Takahara, H., Irie, S., and Fujimoto, D. (2000) Identification of N(omega)-carboxymethylarginine as a novel acid-labile advanced glycation end product in collagen. Biochem. J. 347, 23-27.
29. Davies, M. J., Fu, S., Wang, H., and Dean, R. T. (1999) Stable markers of oxidant damage to proteins and their application in the study of human disease. Free Radical Biol. Med. 27, 1151-1163.
30. Jones, B. N., and Gilligan, J. P. (1983) o-Phthaldialdehyde precolumn derivatization and reversed-phase high-performance liquid chromatography of polypeptide hydrolysates and physiological fluids. J. Chromatogr. 266, 471-482.
31. Dubruc, C., Hermann, P., Haddouche, A., Badarani, M. M., and Thenot, J. P. (1987) Determination of S-carboxymethyl-L-cysteine in plasma by high-performance liquid chromatography with column switching following precolumn derivatization. J. Chromatogr. 417, 208-215.
32. De Schutter, J. A., Van der Weken, G., Van den Bossche, W., and de Moerloose, P. (1988) Determination of S-carboxymethylcysteine in serum by reversed-phase ion-pair liquid chromatography with column switching following pre-column derivatization with o-phthalaldehyde. J. Chromatogr. 428, 301-310.
33. Tawfik, D. S. (2002) Modification of sulfhydryl groups with DTNB. In The Protein Protocols Handbook (Walker, J. M., Ed.) pp 483-484, Humana Press, Totowa, NJ.
34. Ubuka, T., Kodama, H., and Mizuhara, S. (1967) Isolation of S-(carboxymethyl)cysteine from urine. Biochim. Biophys. Acta 141, 266-269.
35. Thorpe, S. R., and Baynes, J. W. (2003) Maillard reaction products in tissue proteins: new products and new perspectives. Amino Acids 25, 275-281.
36. Alt, N., Carson, J. A., Alderson, N. L., Wang, Y., Nagai, R., Henle, T., Thorpe, S. R., and Baynes, J. W. (2004) Chemical modification of muscle protein in diabetes. Arch. Biochem. Biophys. 425, 200-206.
37. Ratner, S., and Clarke, H. T. (1937) The action of formaldehyde upon cysteine. J. Am. Chem. Soc. 59, 200-206.
38. Thornalley, P. J., Langborg, A., and Minhas, H. S. (1999) Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochem. J. 344, 109-116.
39. Aitken, A., and Learmonth, M. (2002) Carboxymethylation of cysteine using iodoacetamide/iodoacetic acid. In The Protein Protocols Handbook (Walker, J. M., Ed.) pp 455-456, Humana Press, Totowa, NJ.
40. Suntornsuk, L. (2001) Direct determination of S-carboxymethyl-L-cysteine in syrups by reversed-phase high-performance liquid chromatography. J. Pharm. Biomed. Anal. 25, 165-170.
41. Baynes, J. W., and Thorpe, S. R. (1999) Role of oxidative stress in diabetic complications: a new perspective on an old paradigm. Diabetes 48, 1-9.
42. Horie, K., Miyata, T., Maeda, K., Miyata, S., Sugiyama, S., Sakai, H., van Ypersole de Strihou, C., Monnier, V. M., Witztum, J. L., and Kurokawa, K. (1997) Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J. Clin. Invest. 100, 2995-3004.
43. Miyata, T., Ishikawa, N., and van Ypersele de Strihou, C. (2003) Carbonyl stress and diabetic complications. Clin. Chem. Lab. Med. 41, 1150-1158.
44. Wolff, S. P., Jiang, Z. Y., and Hunt, J. V. (1991) Protein glycation and oxidative stress in diabetes mellitus and ageing. Free Radical Biol. Med. 10, 339-352.
45. Brownlee, M. (2000) Negative consequences of glycation. Metabolism 49, 9-13.
46. Eaton, J. W., and Dean, R. T. (2000) Diabetes and atherosclerosis. In Atherosclerosis (Dean, R. T., and Kelly, D. T., Eds.) pp 24-45, Oxford University Press, Oxford, U.K.
47. Ceriello, A. (1999) Hyperglycaemia: the bridge between non-enzymatic glycation and oxidative stress in the pathogenesis of diabetic complications. Diabetes, Nutr. Metab. 12, 42-46.
48. Scivittaro, V., Ganz, M. B., and Weiss, M. F. (2000) AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells. Am. J. Physiol. Renal Physiol. 278, F676-F683.
49. Miyata, T., Kurokawa, K., and van Ypersele de Strihou, C. (2000) Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J. Am. Soc. Nephrol. 11, 1744-1752.
50. 2 and other oxidants with sulfhydryl enzymes. Photochem. Photobiol. 28, 743-755.
51. Wang, P. F., McLeish, M. J., Kneen, M. M., Lee, G., and Kenyon, G. L. (2001) An unusually low pK(a) for Cys282 in the active site of human muscle creatine kinase. Biochemistry 40, 11698-11705.
52. Dawson, R. M. C., Elliott, D. C., Elliott, W. H., and Jones, K. M. (1986) Data for Biochemical Research, 3rd ed., Oxford University Press, Oxford, U.K.
53. Thornalley, P. J., McLellan, A. C., Lo, T. W., Benn, J., and Sonksen, P. H. (1996) Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Clin. Sci. 91, 575-582.
54. Beard, K. M., Shangari, N., Wu, B., and O'Brien, P. J. (2003) Metabolism, not autoxidation, plays a role in alpha-oxoaldehyde- and reducing sugar-induced erythrocyte GSH depletion: relevance for diabetes mellitus. Mol. Cell. Biochem. 252, 331-338.
55. Akhand, A. A., Ikeyama, T., Akazawa, S., Kato, M., Hossain, K., Takeda, K., Suzuki, H., Takahashi, M., and Nakashima, I. (2002) Evidence of both extra- and intracellular cysteine targets of protein modification for activation of RET kinase. Biochem. Biophys. Res. Commun. 292, 826-831.
56. Soberman, R. J. (2003) The expanding network of redox signaling: new observations, complexities, and perspectives. J. Clin. Invest. 111, 571-574.
57. Conway, M. E., Poole, L. B., and Hutson, S. M. (2004) Roles for cysteine residues in the regulatory CXXC motif of human mitochondrial branched chain aminotransferase enzyme. Biochemistry 43, 7356-7364.
58. Akhand, A. A., Hossain, K., Kato, M., Miyata, T., Du, J., Suzuki, H., Kurokawa, K., and Nakashima, I. (2001) Glyoxal and methylglyoxal induce aggregation and inactivation of ERK in human endothelial cells. Free Radical Biol. Med. 31, 1228-1235.
59. Akhand, A. A., Hossain, K., Mitsui, H., Kato, M., Miyata, T., Inagi, R., Du, J., Takeda, K., Kawamoto, Y., Suzuki, H., Kurokawa, K., and Nakashima, I. (2001) Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells. Free Radical Biol. Med. 31, 20-30.
60. Du, J., Suzuki, H., Nagase, F., Akhand, A. A., Yokoyama, T., Miyata, T., Kurokawa, K., and Nakashima, I. (2000) Methylglyoxal induces apoptosis in Jurkat leukemia T cells by activating c-Jun N-terminal kinase. J. Cell. Biochem. 77, 333-344.
61. Aimeras, E., Stolz, S., Vollenweider, S., Reymond, P., Mene-Saffrane, L., and Farmer, E. E. (2003) Reactive electrophile species activate defense gene expression in Arabidopsis. Plant J. 34, 205-216.
62. Wondrak, G. T., Cervantes-Laurean, D., Roberts, M. J., Qasem, J. G., Kim, M., Jacobson, E. L., and Jacobson, M. K. (2002) Identification of alpha-dicarbonyl scavengers for cellular protection against carbonyl stress. Biochem. Pharmacol. 63, 361-373.
63. Vasan, S., Zhang, X., Zhang, X., Kapurniotu, A., Bernhagen, J., Teichberg, S., Basgen, J., Wagle, D., Shih, D., Terlecky, I., Bucala, R., Cerami, A., Egan, J., and Ulrich, P. (1996) An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382, 275-278.
64. Forbes, J. M., Yee, L. T., Thallas, V., Lassila, M., Candido, R., Jandeleit-Dahm, K. A., Thomas, M. C., Burns, W. C., Deemer, E. K., Thorpe, S. M., Cooper, M. E., and Allen, T. J. (2004) Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 53, 1813-1823.
65. Liu, J., Masurekar, M. R., Vatner, D. E., Jyothirmayi, G. N., Regan, T. J., Vatner, S. F., Meggs, L. G., and Malhotra, A. (2003) Glycation end-product cross-link breaker reduces collagen and improves cardiac function in aging diabetic heart. Am. J. Physiol. Heart Circ. Physiol. 285, H2587-H2591.
66. Asif, M., Egan, J., Vasan, S., Jyothirmayi, G. N., Masurekar, M. R., Lopez, S., Williams, C., Torres, R. L., Wagle, D., Ulrich, P., Cerami, A., Brines, M., and Regan, T. J. (2000) An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc. Natl. Acad. Sci. U.S.A. 97, 2809-2813.